Keyphrases
CD4 Count
100%
Viral Load
100%
HIV-associated Lymphoma
100%
Lymphoma Diagnosis
80%
HIV Patients
40%
Lymphoma
40%
Infectious Complications
40%
Oncology Clinic
40%
Downtrend
40%
Leading Causes of Death
20%
Early Diagnosis
20%
Pathophysiology
20%
Delayed Diagnosis
20%
Quantitative PCR
20%
Clinical Utility
20%
Clinical High Risk
20%
Lymphocyte Activation
20%
Infection Risk
20%
Response to Therapy
20%
Peripheral Blood
20%
Systemic Therapy
20%
Increased Incidence
20%
Treatment Course
20%
Treatment Outcome
20%
Infection Prophylaxis
20%
Retrospective Chart Review
20%
Potential Change
20%
Complete Response
20%
CD4 Lymphocyte Count
20%
Treatment Complications
20%
HIV Viral Load
20%
Control Algorithm
20%
HIV Control
20%
HIV-negative
20%
Infection Response
20%
Lymphomagenesis
20%
Chemoimmunotherapy
20%
Diffuse Large B-cell Lymphoma (DLBCL)
20%
Treatment Completion
20%
CD4 Level
20%
CD4 Decline
20%
CD4 Lymphopenia
20%
Virologic Control
20%
Haematology Unit
20%
Prognosis Improvement
20%
Lymphoma Therapy
20%
EPOCH Regimen
20%
R-EPOCH
20%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Oncology
18%
Infectious Complication
18%
Lymphocyte
18%
Pathophysiology
9%
Infection
9%
Real-Time Polymerase Chain Reaction
9%
Systemic Therapy
9%
Hematology
9%
Lymphocytopenia
9%
Chemoimmunotherapy
9%
Infection Prevention
9%
Diffuse Large B-Cell Lymphoma
9%
Cyclophosphamide Plus Doxorubicin Plus Etoposide Plus Prednisolone Plus Rituximab Plus Vincristine
9%